Vincerx Pharma, Inc. (VINC)
OTCMKTS
· Delayed Price · Currency is USD
0.0575
-0.0101 (-14.94%)
At close: Apr 25, 2025
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $300.97 thousand as of April 28, 2025. Its market cap has decreased by -99.71% in one year.
Market Cap
300.97K
Enterprise Value
-4.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from 22.32M to 300.97K, a decrease of -98.65%. That is a compound annual growth rate of -58.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 300.97K | -96.60% |
| Dec 31, 2024 | 8.84M | -64.95% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | 292.41M | 1,210.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 746.57M |
| Glass House Brands | 500.84M |
| Elite Pharmaceuticals | 450.22M |
| Northwest Biotherapeutics | 443.51M |
| CytoDyn | 284.32M |
| BioStem Technologies | 245.41M |